Recomendações do Grupo Português do Mieloma Múltiplo para Tratamento do Mieloma Múltiplo

Translated title of the contribution: Multiple Myeloma Treatment Guidelines by the Portuguese Group of Multiple Myeloma

Cristina João, Rui Bergantim, Joana Santos, Celina Afonso, Paulo Bernardo, Henrique Coelho, Carlos Costa, Graça Esteves, José Guilherme Freitas, Rita Gerivaz, Ana Jorge, Ana Macedo, Ana Montalvão, Manuel Neves, Claúdia L. Pedrosa, Susana Pereira, Adriana Roque, Patrícia Seabra, Helena M Silva, Maria P. SilveiraAna Tomé, Fernanda Trigo, Ana Bela Sarmento, Paulo Lúcio, Catarina Geraldes

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)
57 Downloads (Pure)

Abstract

The treatment of multiple myeloma has profoundly changed with the introduction of several innovative therapies. The optimization of therapeutic sequencing through the combined use of the various drugs developed in recent years and the attention given to the characteristics of patients have allowed the reduction of toxicities and increased survival and quality of life of patients with multiple myeloma. These treatment recommendations from the Portuguese Multiple Myeloma Group offer guidance for first-line treatment and progression/relapse situations. These recommendations are given highlighting the data that justify each choice and referring to the respective levels of evidence that support these options. Whenever possible, the respective national regulatory framework is presented. These recommendations constitute an advance towards the best treatment of multiple myeloma in Portugal.

Translated title of the contributionMultiple Myeloma Treatment Guidelines by the Portuguese Group of Multiple Myeloma
Original languagePortuguese
Pages (from-to)517-526
Number of pages10
JournalActa Medica Portuguesa
Volume36
Issue number7-8
DOIs
Publication statusPublished - 3 Jul 2023

Keywords

  • Multiple Myeloma/drug therapy
  • Portugal

Fingerprint

Dive into the research topics of 'Multiple Myeloma Treatment Guidelines by the Portuguese Group of Multiple Myeloma'. Together they form a unique fingerprint.

Cite this